Targeting EGFR to enhance NKT cell-mediated killing of lung cancer cells

Tonya Webb, PhD, Associate Professor at the University of Maryland School of Medicine, discusses her research exploring the therapeutic potential of combination immunotherapy and immunomodulation to treat lung cancer.
► LEARNING OBJECTIVES:
- Current status of non-small cell lung cancer treatment
- Cell therapy using NKT cells and in combination with EGFR inhibitors
- Cancer spheroid models and the importance of modeling the tumor microenvironment
- Using the Maestro Z live-cell analysis platform to evaluate potency of cell- - therapies against cancer spheroids and monolayers, label-free and in real time
► RESOURCES:
IO development brochure: axionbiosystem...
Maestro Z Brochure: axionbiosystem...